In the head-to-head SURMOUNT-5 trial (NEJM, 2025), Mounjaro produced 20.2% average weight loss vs 13.7% for Wegovy over 72 weeks
Bupropion works on dopamine and norepinephrine, directly counteracting the dopamine-reducing effects of GLP-1 receptor activation
The Medicines and Healthcare products Regulatory Agency (MHRA) has updated the product information to include the small risk of severe acute pancreatitis in patients taking GLP-1s, prescribed for treating type 2 diabetes and weight management
The pigmented product also features our new Oilshine Moisture Complex a yummy blend of babassu, coconut, apricot and jojoba oils to help soften and condition lips
Never take two doses at once
Given my results, would an oral supplement realistically raise my levels